Bone Accounts Payable from 2010 to 2025

BBLGW Stock  USD 20.20  0.00  0.00%   
Bone Biologics Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 221.8 K in 2025. Accounts Payable is the amount Bone Biologics Corp owes to suppliers or vendors for products or services received but not yet paid for. It represents Bone Biologics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2014-12-31
Previous Quarter
190.1 K
Current Value
373 K
Quarterly Volatility
456.4 K
 
Yuan Drop
 
Covid
Check Bone Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bone Biologics' main balance sheet or income statement drivers, such as Other Operating Expenses of 11.4 M, Total Operating Expenses of 4.7 M or Gross Profit of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 1.8 or PTB Ratio of 0.43. Bone financial statements analysis is a perfect complement when working with Bone Biologics Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Latest Bone Biologics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Bone Biologics Corp over the last few years. An accounting item on the balance sheet that represents Bone Biologics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Bone Biologics Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Bone Biologics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bone Biologics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Bone Accounts Payable Regression Statistics

Arithmetic Mean182,431
Geometric Mean118,430
Coefficient Of Variation68.61
Mean Deviation96,765
Median125,203
Standard Deviation125,170
Sample Variance15.7B
Range464.5K
R-Value0.39
Mean Square Error14.2B
R-Squared0.15
Significance0.13
Slope10,314
Total Sum of Squares235B

Bone Accounts Payable History

2025221.8 K
2024373 K
2023360.7 K
2022 888.46
202199.9 K
2020465.4 K
201942.9 K

About Bone Biologics Financial Statements

Bone Biologics investors use historical fundamental indicators, such as Bone Biologics' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bone Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable373 K221.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bone Stock Analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.